Zheying Meng

895 citations
22 papers · 749 indexed · h-index 13
Topics
Nanoplatforms for cancer theranostics (7 papers)Nanoparticle-Based Drug Delivery (4 papers)Extracellular vesicles in disease (3 papers)
Journals
Advanced MaterialsSHILAP Revista de lepidopterologíaACS Nano
Partner nations
ChinaDenmarkCanada

In The Last Decade

Zheying Meng

22 papers receiving 742 citations

Peers

Zheying Meng
Comparison fields: 5 of 91
  • Biomedical Engineering 455
  • Materials Chemistry 260
  • Biomaterials 173
  • Molecular Biology 170
  • Pulmonary and Respiratory Medicine 110
Replace Qunqun Bao with:
Qunqun Bao China
Li Su China
Yaqian Du China
He Ding China
Dongya Zhang China
Kuoyang Sun China
Zebin Yang China
Zheying Meng relative to Qunqun Bao China Qunqun Bao's profile →
Citations per field
00.5×
Qunqun Bao · 1×
Citations per year

Countries citing papers authored by Zheying Meng

Since Specialization
Citations

This map shows the geographic impact of Zheying Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zheying Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zheying Meng more than expected).

Fields of papers citing papers by Zheying Meng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zheying Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zheying Meng. The network helps show where Zheying Meng may publish in the future.

Co-authorship network of co-authors of Zheying Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Zheying Meng. A scholar is included among the top collaborators of Zheying Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zheying Meng. Zheying Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 12
2 4
3 1
4 2
5 3
6 112
7 60
8 30
9 31
10 1
11 11
12 61
13 26
14 66
15 4
16 78
17 16
18 33
19 21
20
[MicroRNA-182 modulates high glucose-induced cardiomyocyte hypertrophy via targeting Rac1].
4

About Zheying Meng

Zheying Meng is a scholar working on Biomaterials, Biomedical Engineering and Cancer Research, having authored 22 papers that have together received 749 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (7 papers), Nanoparticle-Based Drug Delivery (4 papers) and Extracellular vesicles in disease (3 papers). The work is most often cited by research in Biomaterials (173 citations), Biomedical Engineering (455 citations) and Materials Chemistry (260 citations). Zheying Meng has collaborated with scholars based in China, Denmark and Canada. Frequent co-authors include Bing Hu, Xiaojun Cai, Yuanyi Zheng, Longchen Wang, Yu Chen, Yang Zhang, Wei Gao, Jianrong Wu, Yuanyi Zheng and E Shen. Their work appears in journals such as Advanced Materials, SHILAP Revista de lepidopterología and ACS Nano.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026